CSIMarket
Pro Dex Inc  (PDEX)
Other Ticker:  
 
 

Pro Dex Inc's Yearly Income from Continued Operations Growth 5 Years

 




PDEX Annual Income from Cont. Operations Growth

2019
2018
2017
2016
2015
Y / Y Annual Income from Cont. Operations Change 155.89 % -66.52 % 488.93 % - -
Annual Income from Cont. Operations (in millions $) $4.15 $1.62 $4.84 $0.82 $-0.40


Annual Income from Cont. Operations Growth Comment
Pro Dex Inc's Annual Income from Cont. Operations for the fiscal year ended 2019, more than doubled to 155.89% to $4.15 millions, from $1.62 millions achieved a year ago. Pro Dex Inc's growrh rate for Income from Continued Operations improved from -66.52 % decline in the fiscal year 2018.

Pro Dex Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2019 Annual Income from Cont. Operations within Healthcare SectorY/Y Income from Continued Operations Growth %2019 Annual Income from Cont. Operations
Mylan N v -95.23 %$ 16.800  millions
Prestige Consumer Healthcare Inc  %$ -35.800  millions
Qiagen N v  %$ -41.455  millions
Alimera Sciences Inc  %$ -10.443  millions
Apollo Medical Holdings Inc -70.68 %$ 17.673  millions
Apyx Medical Corp  %$ -19.706  millions
Inogen Inc -59.59 %$ 20.950  millions
Biotelemetry Inc -28.73 %$ 29.844  millions
Conmed Corporation -29.95 %$ 28.620  millions
Radnet Inc -38.53 %$ 23.440  millions
Petmed Express Inc  1.23 %$ 37.740  millions
Generex Biotechnology Corp  %$ -7.676  millions
Atrion Corp  7.32 %$ 36.761  millions
Ampio Pharmaceuticals, Inc.  %$ -13.630  millions
Eagle Pharmaceuticals inc -55.14 %$ 14.313  millions
National Research Corporation  7.85 %$ 32.406  millions
Fonar Corp -19.40 %$ 20.514  millions
Palatin Technologies Inc  44.81 %$ 35.773  millions
Meridian Bioscience Inc  2.23 %$ 24.382  millions
Lemaitre Vascular Inc -21.83 %$ 17.934  millions
Tenax Therapeutics Inc -60.91 %$ 8.394  millions
Neurocrine Biosciences Inc   75.32 %$ 37.012  millions
Orasure Technologies Inc -18.34 %$ 16.656  millions
Biospecifics Technologies Corp  22.02 %$ 24.470  millions
Orgenesis Inc   36.31 %$ 26.041  millions
Montage Resources Corporation  61.72 %$ 30.446  millions
Anika Therapeutics Inc   45.25 %$ 27.193  millions
Utah Medical Products Inc -20.63 %$ 14.727  millions
Dariohealth Corp  %$ -20.891  millions
Zomedica Pharmaceuticals Corp.  18.84 %$ 19.784  millions
Angiodynamics Inc  %$ -11.146  millions
Orthofix Medical Inc  %$ -28.462  millions
Crh Medical Corporation -36.90 %$ 8.212  millions
Oramed Pharmaceuticals Inc   12.79 %$ 14.355  millions
Delmar Pharmaceuticals, Inc. -28.56 %$ 8.209  millions
Oxford Immunotec Global Plc  %$ -1.340  millions
Check cap Ltd  30.66 %$ 13.836  millions
Cv Sciences Inc  %$ -16.610  millions
Galmed Pharmaceuticals Ltd   107.60 %$ 20.461  millions
Zynex Inc -0.63 %$ 9.492  millions
Neptune Wellness Solutions Inc.  %$ -17.765  millions
Shineco, Inc. -88.29 %$ 0.882  millions
Tactile Systems Technology Inc   65.65 %$ 10.971  millions
Can fite Biopharma Ltd  %$ -9.587  millions
Oncbiomune Pharmaceuticals Inc  %$ -9.402  millions
Iradimed Corp  52.79 %$ 9.631  millions
Heska Corp  %$ -1.731  millions
Enzon Pharmaceuticals, Inc.  %$ -0.979  millions
Lifevantage Corp  28.95 %$ 7.429  millions
Intricon Corporation  %$ -2.064  millions
Kewaunee Scientific Corp -68.54 %$ 1.688  millions
Semler Scientific Inc   200.84 %$ 15.084  millions
Staar Surgical Co  182.77 %$ 14.048  millions
Psychemedics Corp -66.36 %$ 1.542  millions
Insulet Corporation  252.37 %$ 11.600  millions
Xtl Biopharmaceuticals Ltd  %$ -1.347  millions
Bellerophon Therapeutics Inc  %$ -13.267  millions
Electromed, Inc.  3.51 %$ 1.969  millions
American Shared Hospital Services -12.27 %$ 1.430  millions

Other Companies within Healthcare Sector and their 2019 Income from Continued Operations

Y/Y Annual Income from Cont. Operations Growth %

2019 Income from Continued Operations
Davita Inc   14.94 %$ 917.145  millions
Universal Health Services Inc  3.72 %$ 827.543  millions
Quest Diagnostics Inc  12.44 %$ 886.000  millions
Illumina Inc   26.60 %$ 990.000  millions
Edwards Lifesciences Corporation  44.96 %$ 1,046.900  millions
Exelixis Inc -53.48 %$ 321.012  millions
Icon Plc -45.31 %$ 375.856  millions
Nektar Therapeutics -164.68 %$ -440.667  millions
Grifols Sa  9.12 %$ 726.481  millions
United Therapeutics Corporation -117.74 %$ -104.500  millions
Henry Schein Inc  28.99 %$ 725.095  millions
Mettler toledo International Inc   9.46 %$ 561.109  millions
Tenet Healthcare Corp -69.11 %$ 143.000  millions
Jazz Pharmaceuticals Plc  17.06 %$ 523.367  millions
Innoviva inc -53.00 %$ 190.993  millions
Align Technology inc   10.63 %$ 442.776  millions
Idexx Laboratories Inc  13.46 %$ 427.792  millions
Encompass Health Corporation  19.26 %$ 446.400  millions
Bio rad Laboratories Inc   381.02 %$ 1,758.675  millions
Agilent Technologies inc   238.92 %$ 1,071.000  millions
Resmed Inc   28.20 %$ 404.592  millions
Becton Dickinson And Company  296.78 %$ 1,234.000  millions
Iqvia Holdings Inc -20.07 %$ 227.000  millions
Mednax Inc -528.13 %$ -1,150.094  millions
Hill rom Holdings Inc -39.70 %$ 152.200  millions
Coherent inc -78.24 %$ 53.825  millions
Charles River Laboratories International inc   11.81 %$ 254.061  millions
Ionis Pharmaceuticals Inc   41.06 %$ 303.262  millions
Taro Pharmaceutical Industries Ltd  34.08 %$ 282.122  millions
West Pharmaceutical Services Inc   16.82 %$ 241.700  millions
Chemed Corporation  7.00 %$ 219.923  millions
Patterson Companies Inc -58.76 %$ 82.876  millions
Teleflex Incorporated  135.19 %$ 461.981  millions
Masimo Corp  1.38 %$ 196.216  millions
Bruker Corporation  9.39 %$ 198.000  millions
Select Medical Holdings Corp  13.61 %$ 201.031  millions



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

REX's Profile

Stock Price

REX's Financials

Business Description

Fundamentals

Charts & Quotes

REX's News

Suppliers

REX's Competitors

Customers & Markets

Economic Indicators

REX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071